The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans
Open accessAbstract
APOL1 variants are associated with HIV-associated nephropathy and FSGS in African Americans. The prevalence of these variants in African populations with CKD in HIV-1 infection has not been investigated. We determined the role of APOL1 variants in 120 patients with HIV-associated nephropathy and CKD and 108 controls from a South-African black population. Patients with CKD were selected on the basis of histology. Genotypes were successfully determined for APOL1 G1 and G2 variants and 42 single nucleotide polymorphisms, including 18 ancestry informative markers, for 116 patients with CKD (96.7%; 38 patients with HIV-associated nephropathy, 39 patients with HIV-positive CKD, and 39 patients with HIV-negative CKD), and 108 controls (100%). Overall, 79% of patients with HIV-associated nephropathy and 2% of population controls carried two risk alleles. In a recessive model, individuals carrying any combination of two APOL1 risk alleles had 89-fold higher odds (95% confidence interval, 18 to 912; P<0.001) of developing HIV-associated nephropathy compared with HIV-positive controls. Population allele frequencies were 7.3% for G1 and 11.1% for G2. APOL1 risk alleles were not significantly associated with other forms of CKD. These results indicate HIV-positive, antiretroviral therapy-naïve South-African blacks with two APOL1 risk alleles are at very high risk for developing HIV-associated nephropathy. Further studies are required to determine the effect of APOL1 risk variants on kidney diseases in other regions of sub-Saharan Africa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248
Hindorff, L. A., Sethupathy, P., Junkins, H. A., Ramos, E. M., Mehta, J. P., Collins, F. S., & Manolio, T. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903103106 · Cited by 4,013
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Genovese, G., Friedman, D. J., Ross, M. D., Lecordier, L., Uzureau, P., Freedman, B. I., Bowden, D. W., Langefeld, C. D., Oleksyk, T. K., Uscinski Knob, A. L., et al. (2010) · Science · doi:10.1126/science.1193032 · Cited by 2,028
Self-citationAngiogenesis and Inflammation in Peritoneal Dialysis: The Role of Adipocytes
Shi, J., Yu, M., & Sheng, M. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000476017 · Cited by 1,403
APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
Kopp, J. B., Nelson, G. W., Sampath, K., Johnson, R. C., Genovese, G., An, P., Friedman, D., Briggs, W., Dart, R., Korbet, S., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011040388 · Cited by 855
Self-citationUS Renal Data System 2011 Annual Data Report
Collins, A. J., Foley, R. N., Chavers, B., Gilbertson, D., Herzog, C., Johansen, K., Kasiske, B., Kutner, N., Liu, J., St. Peter, W., et al. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.11.015 · Cited by 820
APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease
Parsa, A., Kao, W. H. L., Xie, D., Astor, B. C., Li, M., Hsu, C.-Y., Feldman, H. I., Parekh, R. S., Kusek, J. W., Greene, T. H., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310345 · Cited by 784
Self-citationMYH9 is a major-effect risk gene for focal segmental glomerulosclerosis
Kopp, J. B., Smith, M. W., Nelson, G. W., Johnson, R. C., Freedman, B. I., Bowden, D. W., Oleksyk, T., McKenzie, L. M., Kajiyama, H., Ahuja, T. S., et al. (2008) · Nature Genetics · doi:10.1038/ng.226 · Cited by 711
Self-citationTzur, S., Rosset, S., Shemer, R., Yudkovsky, G., Selig, S., Tarekegn, A., Bekele, E., Bradman, N., Wasser, W. G., Behar, D. M., et al. (2010) · Human Genetics · doi:10.1007/s00439-010-0861-0 · Cited by 653
MYH9 is associated with nondiabetic end-stage renal disease in African Americans
on behalf of the Family Investigation of Nephropathy and Diabetes (FIND) Research Group, Kao, W. H. L., Klag, M. J., Meoni, L. A., Reich, D., Berthier-Schaad, Y., Li, M., Coresh, J., Patterson, N., Tandon, A., et al. (2008) · Nature Genetics · doi:10.1038/ng.232 · Cited by 649
Self-citationGlobal and regional distribution of HIV-1 genetic subtypes and recombinants in 2004
Hemelaar, J., Gouws, E., Ghys, P. D., & Osmanov, S. (2006) · AIDS · doi:10.1097/01.aids.0000247564.73009.bc · Cited by 629
Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1
Nichols, B., Jog, P., Lee, J. H., Blackler, D., Wilmot, M., D'Agati, V., Markowitz, G., Kopp, J. B., Alper, S. L., Pollak, M. R., et al. (2015) · Kidney International · doi:10.1038/ki.2014.270 · Cited by 355
Self-citationAnemia and end-stage renal disease in patients with type 2 diabetes and nephropathy
Mohanram, A., Zhang, Z., Shahinfar, S., Keane, W. F., Brenner, B. M., & Toto, R. D. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00863.x · Cited by 245
APOL1 Localization in Normal Kidney and Nondiabetic Kidney Disease
Madhavan, S. M., O'Toole, J. F., Konieczkowski, M., Ganesan, S., Bruggeman, L. A., & Sedor, J. R. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011010069 · Cited by 239
Evolution of the primate trypanolytic factor APOL1
Thomson, R., Genovese, G., Canon, C., Kovacsics, D., Higgins, M. K., Carrington, M., Winkler, C. A., Kopp, J., Rotimi, C., Adeyemo, A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400699111 · Cited by 225
Self-citationHan, T. M., Naicker, S., Ramdial, P. K., & Assounga, A. G. (2006) · Kidney International · doi:10.1038/sj.ki.5000339 · Cited by 223
Self-citationAPOL1 Kidney Risk Alleles: Population Genetics and Disease Associations
Limou, S., Nelson, G. W., Kopp, J. B., & Winkler, C. A. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.06.005 · Cited by 216
Self-citationY-Chromosomal Variation in Sub-Saharan Africa: Insights Into the History of Niger-Congo Groups
de Filippo, C., Barbieri, C., Whitten, M., Mpoloka, S. W., Gunnarsdottir, E. D., Bostoen, K., Nyambe, T., Beyer, K., Schreiber, H., de Knijff, P., et al. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msq312 · Cited by 177
Collapsing glomerulopathy in HIV and non-HIV patients: A clinicopathological and follow-up study
Laurinavicius, A., Hurwitz, S., & Rennke, H. G. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00769.x · Cited by 176
Nasiri, H., Forouzandeh, M., Rasaee, M. J., & Rahbarizadeh, F. (2005) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20083 · Cited by 158
APOL1 Variants Increase Risk for FSGS and HIVAN but Not IgA Nephropathy
Papeta, N., Kiryluk, K., Patel, A. M., Sterken, R., Kacak, N., Snyder, H. J., Imus, P. H., Mhatre, A. N., Lawani, A. K., Julian, B. A., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011040434 · Cited by 127
APOL1 Risk Variants Predict Histopathology and Progression to ESRD in HIV-Related Kidney Disease
Fine, D. M., Wasser, W. G., Estrella, M. M., Atta, M. G., Kuperman, M. B., Shemer, R., Rajasekaran, A., Tzur, S., Racusen, L. C., & Skorecki, K. L. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060562 · Cited by 122
Genetic Variation in APOL1 Associates with Younger Age at Hemodialysis Initiation
Kanji, Z., Powe, C. E., Wenger, J., Huang, C., Ankers, E. D., Sullivan, D. A., Collerone, G., Powe, N. R., Tonelli, M. A., Bhan, I., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121234 · Cited by 119
Kopp, J. B., & Winkler, C. A. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s83.10.x · Cited by 116
Self-citationGene–Gene and Gene–Environment Interactions in Apolipoprotein L1 Gene-Associated Nephropathy
Freedman, B. I., & Skorecki, K. L. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01330214 · Cited by 113
Ulasi, I., Tzur, S., Wasser, W. G., Shemer, R., Kruzel-Davila, E., Feigin, E., Ijoma, C. K., Onodugo, O. D., Okoye, J. U., Arodiwe, E. B., et al. (2013) · Nephron Clinical Practice · doi:10.1159/000353223 · Cited by 108
Ko, W., Rajan, P., Gomez, F., Scheinfeldt, L., An, P., Winkler, C. A., Froment, A., Nyambo, T., Omar, S. A., Wambebe, C. O., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.05.014 · Cited by 107
Self-citationTzur, S., Rosset, S., Skorecki, K. L., & Wasser, W. G. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr796 · Cited by 94
Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update
Nel, J. S., Dlamini, S. K., Meintjes, G., Burton, R., Black, J. M., Davies, N., Hefer, E., Maartens, G., Mangena, P., Mathe, M., et al. (2020) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v21i1.1115 · Cited by 93
Guidelines for antiretroviral therapy in adults
Meintjes, G., & Maartens, G. (2012) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v13i3.125 · Cited by 91
Behar, D. M., Kedem, E., Rosset, S., Haileselassie, Y., Tzur, S., Kra-Oz, Z., Wasser, W. G., Shenhar, Y., Shahar, E., Hassoun, G., et al. (2011) · American Journal of Nephrology · doi:10.1159/000332378 · Cited by 75
Novitsky, V., Ndung’u, T., Wang, R., Bussmann, H., Chonco, F., Makhema, J. M., Gruttola, V. D., Walker, B. D., & Essex, M. (2011) · AIDS · doi:10.1097/qad.0b013e3283471eb2 · Cited by 64
Meehan, S. M., Kim, L., & Chang, A. (2012) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-012-1213-3 · Cited by 16
Cited by
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Focal Segmental Glomerulosclerosis
Rosenberg, A. Z., & Kopp, J. B. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05960616 · Cited by 562
Self-citationDiversity and inclusion in genomic research: why the uneven progress?
Bentley, A. R., Callier, S., & Rotimi, C. N. (2017) · Journal of Community Genetics · doi:10.1007/s12687-017-0316-6 · Cited by 357
Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice
Beckerman, P., Bi-Karchin, J., Park, A. S. D., Qiu, C., Dummer, P. D., Soomro, I., Boustany-Kari, C. M., Pullen, S. S., Miner, J. H., Hu, C.-A. A., et al. (2017) · Nature Medicine · doi:10.1038/nm.4287 · Cited by 344
Self-citationAPOL1 Nephropathy: From Genetics to Clinical Applications
Friedman, D. J., & Pollak, M. R. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.15161219 · Cited by 270
Metadata
- Authors
- Kasembeli, A. N., Duarte, R., Ramsay, M., Mosiane, P., Dickens, C., Dix-Peek, T., Limou, S., Sezgin, E., Nelson, G. W., Fogo, A. B., Goetsch, S., Kopp, J. B., Winkler, C. A., & Naicker, S.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2015-11
- Volume
- 26
- Issue
- 11
- Pages
- 2882-2890
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2159281103
- Cited by
- 326
- References
- 33
- FWCI
- 23.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.